← Back to Clinical Trials
Recruiting NCT06539026
Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia
Trial Parameters
Condition Pre-Eclampsia
Sponsor Ain Shams University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2024-08-15
Completion 2024-11-29
All Conditions
Interventions
fluid therapy, 300 ml of crystalloid Ringer's solution.
Brief Summary
The routine assessment of fluid status depends on clinical evaluation and invasive monitoring. The clinical assessment lacks objectivity and the invasive monitoring carries risks. Point of care ultrasound (POCUS) parameters can be useful as early markers of fluid status and were used in safe fluid assessment in term pregnancy and preeclampsia.
Eligibility Criteria
Inclusion Criteria: * Critically ill pre-eclamptic patients for cesarean section Exclusion Criteria: * Patient refusal * severe cardiovascular disease ( ejection fraction \< 40 mmHg ), tricuspid regurge. * contraindication for spinal anesthesia. * failure to perform spinal anesthesia. * severe hepatic. * renal dysfunction
Related Trials
NCT07245056
Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia
View Trial →
NCT06779916
Autophagy/Apoptosis Balance in Placental Vascular Pathologies
View Trial →
NCT06539026
Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia
View Trial →